Intravenous Administration of Metoprolol Versus Biatrial Pacing in the Prevention of Atrial Fibrillation After Cardiac Surgery
Information source: Kuopio University Hospital
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Atrial Fibrillation; Biatrial Pacing; Metoprolol
Intervention: metoprolol, biatrial pacing (Other)
Phase: Phase 4
Status: Completed
Sponsored by: Kuopio University Hospital
Summary
The aim of the study is to compare the effectiviness of biatrial pacing versus intravenous
administration of metoprolol in the prevention of atrial fibrillation after cardiac surgery
Clinical Details
Official title: Intravenous Metoprolol Versus Biatrial Pacing in the Prevention of Atrial Fibrillation After Cardiac Surgery
Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Primary outcome: biatriac pacingIncidence of atrial fibrillation
Eligibility
Minimum age: N/A.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- elective CABG and aortic valve cardiac patients,
- previous use of beta blocker
Exclusion Criteria:
- Previous episodes of Atrial fibrillation or flutter,
- II or II degree atrioventricular block, uncontrolled heart failure
- Sick sinus syndrome
Locations and Contacts
Halonen Jari, Kuopio FIN-70211, Finland
Additional Information
Starting date: January 2007
Last updated: November 23, 2011
|
